valinomycin and Onchocerciasis--Ocular

Onchocerciasis, or river blindness, is a neglected tropical disease that affects more than 37 million people worldwide, primarily in Africa and Central and South America. We have disclosed evidence that the larval-stage-specific chitinase, OvCHT1, may be a potential biological target for affecting nematode development. On the basis of screening efforts, closantel, a known anthelmintic drug, was discovered as a potent and highly specific OvCHT1 inhibitor. Originally, closantel's anthelmintic mode of action was believed to rely solely on its role as a proton ionophore; thus, the impact of each of its biological activities on O. volvulus L3 molting was investigated. Structure-activity relationship studies on an active closantel fragment are detailed, and remarkably, by use of a simple salicylanilide scaffold, compounds acting only as protonophores or chitinase inhibitors were identified. From these data, unexpected synergistic protonophore and chitinase inhibition activities have also been found to be critical for molting in O. volvulus L3 larvae.

Topics: Animals; Chitinases; Drug Design; Enzyme Inhibitors; Epithelial Cells; Filaricides; Haplorhini; HEK293 Cells; Humans; Ionophores; Larva; Molecular Structure; Molting; Onchocerca volvulus; Onchocerciasis; Onchocerciasis, Ocular; Protons; Salicylanilides; Structure-Activity Relationship